BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36111375)

  • 21. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo.
    Flick MJ; Du X; Witte DP; Jirousková M; Soloviev DA; Busuttil SJ; Plow EF; Degen JL
    J Clin Invest; 2004 Jun; 113(11):1596-606. PubMed ID: 15173886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crosslinking of soluble fibrin and fibrinogen.
    Selmayr E; Mahn I; Müller-Berghaus G
    Thromb Res; 1985 Aug; 39(4):467-74. PubMed ID: 2864751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability.
    Wolberg AS; Sang Y
    Arterioscler Thromb Vasc Biol; 2022 Aug; 42(8):931-941. PubMed ID: 35652333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. von Willebrand factor-binding protein (vWbp)-activated factor XIII and transglutaminase 2 (TG2) promote cross-linking between FnBPA from Staphylococcus aureus and fibrinogen.
    Motta C; Pellegrini A; Camaione S; Geoghegan J; Speziale P; Barbieri G; Pietrocola G
    Sci Rep; 2023 Jul; 13(1):11683. PubMed ID: 37468579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
    Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
    Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Variants in the
    Simurda T; Brunclikova M; Asselta R; Caccia S; Zolkova J; Kolkova Z; Loderer D; Skornova I; Hudecek J; Lasabova Z; Stasko J; Kubisz P
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elimination of the fibrinogen integrin α
    Nasimuzzaman M; Arumugam PI; Mullins ES; James JM; VandenHeuvel K; Narciso MG; Shaw MA; McGraw S; Aronow BJ; Malik P
    Blood Adv; 2019 May; 3(9):1519-1532. PubMed ID: 31076408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.
    Beckman JD; Holle LA; Wolberg AS
    J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
    Hevessy Z; Haramura G; Boda Z; Udvardy M; Muszbek L
    Thromb Haemost; 1996 Jan; 75(1):161-7. PubMed ID: 8713796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation.
    Greenberg CS; Miraglia CC
    Blood; 1985 Aug; 66(2):466-9. PubMed ID: 2861869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.
    Standeven KF; Ariëns RA; Whitaker P; Ashcroft AE; Weisel JW; Grant PJ
    Diabetes; 2002 Jan; 51(1):189-97. PubMed ID: 11756340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of plasma factor XIII binding to fibrin in vitro.
    Greenberg CS; Dobson JV; Miraglia CC
    Blood; 1985 Nov; 66(5):1028-34. PubMed ID: 2413926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered fibrinogen γ-chain cross-linking in mutant fibrinogen-γ
    Poole LG; Schmitt LR; Schulte A; Groeneveld DJ; Cline HM; Sang Y; Hur WS; Wolberg AS; Flick MJ; Hansen KC; Luyendyk JP
    J Thromb Haemost; 2023 Aug; 21(8):2175-2188. PubMed ID: 37062522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanism.
    Joshi N; Kopec AK; Ray JL; Cline-Fedewa H; Nawabi A; Schmitt T; Nault R; Zacharewski TR; Rockwell CE; Flick MJ; Luyendyk JP
    Blood; 2016 Jun; 127(22):2751-62. PubMed ID: 26921287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis.
    Luyendyk JP; Kassel KM; Allen K; Guo GL; Li G; Cantor GH; Copple BL
    Am J Pathol; 2011 Mar; 178(3):1117-25. PubMed ID: 21356363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.
    Souri M; Osaki T; Ichinose A
    J Biol Chem; 2015 May; 290(19):12027-39. PubMed ID: 25809477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice.
    Hattori N; Degen JL; Sisson TH; Liu H; Moore BB; Pandrangi RG; Simon RH; Drew AF
    J Clin Invest; 2000 Dec; 106(11):1341-50. PubMed ID: 11104787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.